City Insurance PLC. announcements
354 Dhaka Stock Exchange announcements for City Insurance PLC. (CITYGENINS) since 2008: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (21).
- (Q3 Un-audited): EPS was Tk. 0.64 for July-September 2024 as against Tk. 0.77 for July-September 2023; EPS was Tk. 2.37
(Q3 Un-audited): EPS was Tk. 0.64 for July-September 2024 as against Tk. 0.77 for July-September 2023; EPS was Tk. 2.37 for January-September 2024 as against Tk. 2.12 for January-September 2023. NOCFPS was Tk. 1.54 for January-September 2024 as against Tk. 1.84 for January-September 2023. NAV per share was Tk. 21.68 as on September 30, 2024 and Tk. 20.40 as on December 31, 2023. Reasons for deviation: EPS has been increased for the period from 01 January 2024 to 30 September 2024 (cont.)
- Q3 Financials
(Cont. news of CITYGENINS): in comparison to the same period of the previous year because of premium income, investment and others income have been increased and re-insurance expense has been decreased. NOCFPS has been decreased in comparison to the same period of the previous year because of the company's claim and others payment have been increased. NAV per share has been increased in comparison to the same period of the previous year because of the company's investments in FDR has been increased. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 23, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.
- (Q2 Un-audited): EPS was Tk. 0.89 for April-June 2024 as against Tk. 0.81 for April-June 2023; EPS was Tk. 1.74 for Janu
(Q2 Un-audited): EPS was Tk. 0.89 for April-June 2024 as against Tk. 0.81 for April-June 2023; EPS was Tk. 1.74 for January-June 2024 as against Tk. 1.35 for January-June 2023. NOCFPS was Tk. 1.42 for January-June 2024 as against Tk. 1.25 for January-June 2023. NAV per share was Tk. 21.06 as on June 30, 2024 and Tk. 20.40 as on December 31, 2023. Reasons for deviation in EPS, NOCFPS and NAVPS: (cont.)
- Q2 Financials
(Cont. news of CITYGENINS): EPS has been increased because of claim and re-insurance expenses have been decreased and investment and others income have been increased. NOCFPS has been increased because the company's re-insurance, claim and others payment have been decreased. NAVPS has been increased because the company's investments in FDR has been increased. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 31, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2024.
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the Rating of the Company as "AAA" in the long term along with Stable outlook in consideration of audited financials of the Company up to December 31, 2023; unaudited financials up to March 31, 2024 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Name Change of the Company
Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'City Insurance PLC.' instead of 'City General Insurance Co. Ltd.' with effect from July 14, 2024. Other things (except name) will remain unchanged.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2023 to the respective shareholders.
- (Q1 Un-audited): EPS was Tk. 0.85 for January-March 2024 as against Tk. 0.54 for January-March 2023. NOCFPS was Tk. 0.79
(Q1 Un-audited): EPS was Tk. 0.85 for January-March 2024 as against Tk. 0.54 for January-March 2023. NOCFPS was Tk. 0.79 for January-March 2024 as against Tk. 0.48 for January-March 2023. NAV per share was Tk. 20.80 as on March 31, 2024 and Tk. 20.40 as on December 31, 2023. Reasons for deviations: EPS has been increased because of (cont.)
- Q1 Financials
(Continuation news of CITYGENINS): investment and others income has been increased steadily and management expenses have been decreased. NOCFPS has been increased because the company's management expenses and re-insurance payment have been decreased. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2024.
- Update of Information
The company has requested the concerned Brokerage Houses/DPs to provide the statement both hard and soft copy to [email protected] with details of their margin loan holders entitled to Final Dividend 2023 on or before 21 March 2024. The statement should include Shareholder's name, BOID Number, Email, client-wise shareholding position, contact person etc. The record date was 12 March 2024.
- Resumption after Record date
Trading of the shares of the company will resume on 13.03.2024.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 12.03.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 10.03.2024 to 11.03.2024 and trading of the shares will remain suspended on record date i.e., 12.03.2024.
- The Board of Directors has recommended 12.00\% Cash Dividend for the year ended December 31, 2023. Date of AGM: 28.03.20
The Board of Directors has recommended 12.00\% Cash Dividend for the year ended December 31, 2023. Date of AGM: 28.03.2024, Time: 11:00 AM, Venue: Hybrid System i.e., at BCIC Auditorium 30-31 Dilkusha C/A, Dhaka with physical presence and also Digital Platform. Record date: 12.03.2024. (cont.1)
- (Cont. news of CITYGENINS): The Company has also reported EPS of Tk. 3.02, NAV per share of Tk. 20.40 and NOCFPS of Tk.
(Cont. news of CITYGENINS): The Company has also reported EPS of Tk. 3.02, NAV per share of Tk. 20.40 and NOCFPS of Tk. 2.53 for the year ended December 31, 2023 as against Tk. 2.25, Tk. 18.57 and Tk. 5.59 respectively for the year ended December 31, 2022. Reasons for deviation in EPS, NAVPS and NOCFPS: (cont.2)
The first part of this announcement is missing from the archive. - Dividend Declaration
(Cont. news of CITYGENINS): EPS has been increased because the company's underwriting profit and others income have been increased significantly. NOCFPS has been decreased because the company's premium income has been decreased and re-insurance payment has been increased. NAVPS has been increased because the company's investments in share, Govt. Treasury Bond and FDR have been increased sharply. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (19.02.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 18, 2024 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2023.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.